UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 110

Sortiert nach

Savings without changing: How to use the MyPKfit® device to improve treatment strategies in a cohort of patients with haemophilia A

Thrombosis research, 2019-11, Vol.183, p.1-3

2019

Link zum Volltext

Verfügbarkeit prüfen

Updates on Novel Non-Replacement Drugs for Hemophilia

Pharmaceuticals (Basel, Switzerland), 2022-09, Vol.15 (10), p.1183

2022

Link zum Volltext

Verfügbarkeit prüfen

How haemophilia A impacts severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) treatment: a case report

Journal of thrombosis and thrombolysis, 2020-11, Vol.50 (4), p.795-798

2020

Link zum Volltext

Verfügbarkeit prüfen

Personalized Prophylaxis with myPKFiTCE: A Real-World Cost-Effectiveness Analysis in Haemophilia A Patients

Medicina (Kaunas, Lithuania), 2024-01, Vol.60 (1), p.34

2024

Link zum Volltext

Verfügbarkeit prüfen

Intracranial haemorrhage in children and adults with haemophilia A and B: a literature review of the last 20 years

Blood transfusion = Trasfusione del sangue, 2019-09, Vol.17 (5), p.378-384

2019

Link zum Volltext

Verfügbarkeit prüfen

Regenerative Surgery with Dental Implant Rehabilitation in a Haemophiliac Patient

TH open : companion journal to thrombosis and haemostasis, 2021-01, Vol.5 (1), p.e104-e106

2021

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of peripheral blood stem cell mobilization and collection: a single-center experience in 190 allogeneic donors

Transfusion (Philadelphia, Pa.), 2012-11, Vol.52 (11), p.2387-2394

2012

Link zum Volltext

Verfügbarkeit prüfen

Intracranial Haemorrhage in Haemophilia Patients Is Still an Open Issue: The Final Results of the Italian EMO.REC Registry

Journal of clinical medicine, 2022-04, Vol.11 (7), p.1969

2022

Link zum Volltext

Verfügbarkeit prüfen

Concizumab as a Subcutaneous Prophylactic Treatment Option for Patients with Hemophilia A or B: A Review of the Evidence and Patient's Perspectives

Journal of blood medicine, 2022-01, Vol.13, p.191-199

Pasca, Samantha

2022

Link zum Volltext

Verfügbarkeit prüfen

Real-World Clinical Outcomes and Replacement Factor VIII Consumption in Patients with Haemophilia A in Italy: A Comparison between Prophylaxis Pre and Post Octocog Alfa (BAY 81-8973)

Journal of clinical medicine, 2022-06, Vol.11 (12), p.3434

2022

Link zum Volltext

Verfügbarkeit prüfen

Treatment With Efmoroctocog Alfa (Elocta®) in Hemophilia: A Case Series

Clinical management issues, 2020-10, Vol.14 (1)

2020

Link zum Volltext

Verfügbarkeit prüfen

Haemophilia A/B carriers: haemorrhagic burden of disease and open issues

Blood transfusion = Trasfusione del sangue, 2020-11, Vol.18 (6), p.496-497

2020

Link zum Volltext

Verfügbarkeit prüfen

Thrombophilic Mutations as Risk Factor for Retinal Vein Occlusion

Clinical and applied thrombosis/hemostasis, 2015-05, Vol.21 (4), p.373-377

2015

Link zum Volltext

Verfügbarkeit prüfen

Light and shadows of the new therapies for haemophilia treatment in the COVID-19 era

Blood transfusion = Trasfusione del sangue, 2021-01, Vol.19 (1), p.73-76

2021

Link zum Volltext

Verfügbarkeit prüfen

Specific serum biomarkers to assess the bone health in a group of hemophilia A carriers: Data from the CAR.BONE study

Thrombosis research, 2024-01, Vol.233, p.200-202

2024

Link zum Volltext

Verfügbarkeit prüfen

The pharmacokinetics of recombinant FXIII (catridecacog) from the MENTORTM2 trial to a real-world study: a head-to-head comparison

Journal of thrombosis and thrombolysis, 2022-11, Vol.54 (4), p.593-596

2022

Link zum Volltext

Verfügbarkeit prüfen

Prothrombin Complex Concentrate Such as Therapy and Prophylaxis in Factor X-Deficient Patient (Friuli Variant)

Clinical and applied thrombosis/hemostasis, 2011-08, Vol.17 (4), p.332-336

2011

Link zum Volltext

Verfügbarkeit prüfen

PK-driven prophylaxis versus standard prophylaxis: When a tailored treatment may be a real and achievable cost-saving approach in children with severe hemophilia A

Thrombosis research, 2017-09, Vol.157, p.58-63

2017

Link zum Volltext

Verfügbarkeit prüfen

Very high risk of intracranial hemorrhage and severe outcomes in adult patients with mild hemophilia: Sub-analysis of the EMO.REC Registry

Thrombosis research, 2023-01, Vol.221, p.35-36

2023

Link zum Volltext

Verfügbarkeit prüfen

Emicizumab in acquired hemophilia A: pros and cons of a new approach to the prevention and treatment of bleeding

Blood transfusion = Trasfusione del sangue, 2023-11, Vol.21 (6), p.549-556

2023

Link zum Volltext

Verfügbarkeit prüfen

Correction to: The pharmacokinetics of recombinant FXIII (catridecacog) from the MENTORTM2 trial to a real-world study: a head-to-head comparison

Journal of thrombosis and thrombolysis, 2023, Vol.55 (1), p.195-195

2023

Link zum Volltext

Verfügbarkeit prüfen

The sudden and unexpected appearance of inhibitors in a previously treated severe haemophilia B patient after the switch to albutrepenonacog alpha

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-09, Vol.24 (5), p.e372-e375

2018

Link zum Volltext

Verfügbarkeit prüfen

The evolution of physiotherapy in the multidisciplinary management of persons with haemophilia (PWH): A scoping review

Haemophilia : the official journal of the World Federation of Hemophilia, 2023-01, Vol.29 (1), p.11-20

2023

Link zum Volltext

Verfügbarkeit prüfen

Albumin-Fusion Recombinant FIX in the Management of People with Hemophilia B: An Evidence-Based Review

Drug design, development and therapy, 2022-01, Vol.16, p.3109-3116

2022

Link zum Volltext

Verfügbarkeit prüfen

Immune tolerance induction rescue with turoctocog-alfa in a poor risk haemophilia A inhibitor young child: the history of a success

Blood coagulation & fibrinolysis, 2018-07, Vol.29 (5), p.465-468

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 110

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(102)
Mit Volltextzugriff
(102)

Publikationsform

Artikel
(105)
Berichte
(5)

Sprache

Englisch
(110)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Savings without changing: How to use the MyPKfit® device to improve treatment strategies in a cohort of patients with haemophilia A

Updates on Novel Non-Replacement Drugs for Hemophilia

How haemophilia A impacts severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) treatment: a case report

Personalized Prophylaxis with myPKFiTCE: A Real-World Cost-Effectiveness Analysis in Haemophilia A Patients

Intracranial haemorrhage in children and adults with haemophilia A and B: a literature review of the last 20 years

Regenerative Surgery with Dental Implant Rehabilitation in a Haemophiliac Patient

Efficacy and safety of peripheral blood stem cell mobilization and collection: a single-center experience in 190 allogeneic donors

Intracranial Haemorrhage in Haemophilia Patients Is Still an Open Issue: The Final Results of the Italian EMO.REC Registry

Concizumab as a Subcutaneous Prophylactic Treatment Option for Patients with Hemophilia A or B: A Review of the Evidence and Patient's Perspectives

Real-World Clinical Outcomes and Replacement Factor VIII Consumption in Patients with Haemophilia A in Italy: A Comparison between Prophylaxis Pre and Post Octocog Alfa (BAY 81-8973)

Treatment With Efmoroctocog Alfa (Elocta®) in Hemophilia: A Case Series

Haemophilia A/B carriers: haemorrhagic burden of disease and open issues

Thrombophilic Mutations as Risk Factor for Retinal Vein Occlusion

Light and shadows of the new therapies for haemophilia treatment in the COVID-19 era

Specific serum biomarkers to assess the bone health in a group of hemophilia A carriers: Data from the CAR.BONE study

The pharmacokinetics of recombinant FXIII (catridecacog) from the MENTORTM2 trial to a real-world study: a head-to-head comparison

Prothrombin Complex Concentrate Such as Therapy and Prophylaxis in Factor X-Deficient Patient (Friuli Variant)

PK-driven prophylaxis versus standard prophylaxis: When a tailored treatment may be a real and achievable cost-saving approach in children with severe hemophilia A

Very high risk of intracranial hemorrhage and severe outcomes in adult patients with mild hemophilia: Sub-analysis of the EMO.REC Registry

Emicizumab in acquired hemophilia A: pros and cons of a new approach to the prevention and treatment of bleeding

Correction to: The pharmacokinetics of recombinant FXIII (catridecacog) from the MENTORTM2 trial to a real-world study: a head-to-head comparison

The sudden and unexpected appearance of inhibitors in a previously treated severe haemophilia B patient after the switch to albutrepenonacog alpha

The evolution of physiotherapy in the multidisciplinary management of persons with haemophilia (PWH): A scoping review

Albumin-Fusion Recombinant FIX in the Management of People with Hemophilia B: An Evidence-Based Review

Immune tolerance induction rescue with turoctocog-alfa in a poor risk haemophilia A inhibitor young child: the history of a success

Suchergebnisse filtern